Colon cancer is one of the commonest cancers in the Western world. Environmental factors appear to predominate as exemplified by a change in incidence in colon cancer within 20 years when people emigrate from a low- to a high-incidence country. It had been suggested that a diet high in energy, fat, and meat content and low in fiber content is most likely responsible. Epidemiologic observations have pointed to a potential effect of calcium or/and vitamin D in reducing the incidence of colon cancer. Other studies have shown a reduction in preneoplastic colon adenomas with increased calcium or/and vitamin D intake. High fat diets were shown to be accompanied by an increase in fecal fatty acids and bile acids or a change in bile acid composition. Soluble fatty acids and bile acids then could interact with the colonic epithelium inducing cell damage and increased proliferation. A hypothesis was developed suggesting that calcium supplementation and increased calcium in the colonic lumen would precipitate these bile acids and fatty acids. Examination of the effect of supplemental calcium or calcium in dairy foods showed a major reduction in fecal bile acids and fatty acids in solution in volunteers and accompanied by a reduction in cytolytic activity. Studies then were performed in patients at risk for colon cancer seeking a change in proliferative biomarkers of risk from a high-risk to a low-risk pattern with supplemental calcium administration. These studies generally have shown a beneficial effect of the addition of calcium at 1.2-2 gm per day in addition to a regular diet for periods of 2 to 6 months. A recently published study also demonstrated that a diet, in which low-fat dairy foods containing an average of about 825 mg of calcium, significantly improved proliferative biomarkers as well as two differentiation bio-markers of risk for colon cancer from a high- to a low-risk pattern. These observations, together with recent studies showing reduced adenomatous polyp recurrence when supplemental calcium was provided, demonstrate the potential of calcium and perhaps vitamin D as chemopreventive agents for colorectal neoplasia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1749-6632.1999.tb08730.x | DOI Listing |
S Afr J Surg
December 2024
Centre for Global Surgery, Department of Global Health, Stellenbosch University, South Africa.
Background: Colorectal cancer (CRC) is the fifth most common cancer in sub-Saharan Africa (SSA) and the third most common in South Africa (SA). CRC characteristics in SSA are not well described. The aim is to describe patient characteristics and anatomic location of colorectal adenocarcinoma (CRC-AC) in SA.
View Article and Find Full Text PDFAm J Surg Pathol
January 2025
Department of Pathology.
Despite being designated as "noncarcinogenic" human papillomavirus (HPV) types, mono-infection with HPV6 or HPV11 has been found in squamous cell carcinomas (SCCs) at specific sites, including the larynx, penis, anus, and rarely, the lower female genital tract. The association between clinicopathologic features, viral status, and the carcinogenic mechanisms related to these low-risk HPVs remains unclear. The current study characterizes a series of low-risk HPV6 and HPV11-associated SCCs of the uterine cervix (6 cases) and vulva (2 cases).
View Article and Find Full Text PDFRadiol Case Rep
March 2025
Department of Radiology, Hôtel-Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon.
Intussusception in adults is a rare condition often associated with a pathological lead point, which is frequently malignant but can occasionally be benign, such as colonic lipomas. We report the case of a 60-year-old male who presented with colicky abdominal pain, and a computed tomography (CT) revealed a colo-colic intussusception caused by a 6 cm lipoma in the transverse colon, accompanied by ischemic changes in the colonic mucosa. The patient underwent a right hemicolectomy, and histopathology confirmed the benign nature of the lesion.
View Article and Find Full Text PDFBMJ Oncol
September 2023
Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.
Objective: Breast, lung, colon cancers are the 'big killers' in oncology. Access to innovative treatments lags behind in low-income and middle-income countries. We investigated the geographic distribution of industry-sponsored trials; and whether results were reported in clinical trial registries.
View Article and Find Full Text PDFBMJ Oncol
October 2024
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Clinical endpoints, such as overall survival, directly measure relevant outcomes. Surrogate endpoints, in contrast, are intermediate, stand-in measures of various tumour-related metrics and include tumour growth, tumour shrinkage, blood results, etc. Surrogates may be a time point measurement, that is, tumour shrinkage at some point (eg, response rate) or biomarker-assessed disease status, measured at given time points (eg, circulating tumour DNA, ctDNA).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!